{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:35:20Z","timestamp":1784097320221,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T17:54:38Z","timestamp":1587059678000},"page":"3942-3951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-5181","authenticated-orcid":false,"given":"Catalina","family":"Avenda\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Celis-Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"D\u00edaz-Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibett","family":"Rodr\u00edguez-Habibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Oviedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"Curtidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Garc\u00eda-Castiblanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredy","family":"Mart\u00ednez-Panqueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Camargo-Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel D.","family":"Boh\u00f3rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnolia","family":"Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel E.","family":"Patarroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A.","family":"Patarroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.006_b0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coviro.2017.11.013","article-title":"Understanding the transmission of foot-and-mouth disease virus at different scales","volume":"28","author":"Paton","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1966","article-title":"Interplay of foot and mouth disease virus with cell - mediated and humoral immunity of host","volume":"28","author":"Abubakar","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.meegid.2018.01.020","article-title":"Molecular epidemiology, evolution and phylogeny of foot-and-mouth disease virus","volume":"59","author":"Jamal","year":"2018","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2018.02.005","article-title":"The need for improved vaccines against foot-and-mouth disease","volume":"29","author":"de los Santos","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-1702(02)00257-5","article-title":"Molecular basis of pathogenesis of FMDV","volume":"91","author":"Mason","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.04.006_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tvjl.2010.02.018","article-title":"Foot-and-mouth disease: The question of implementing vaccinal control during an epidemic","volume":"188","author":"Hutber","year":"2011","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2020.04.006_b0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","article-title":"Foot and mouth disease vaccine strain selection: current approaches and future perspectives","volume":"17","author":"Mahapatra","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.04.006_b0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetmic.2016.12.018","article-title":"Foot-and-mouth disease vaccines","volume":"206","author":"Diaz-San Segundo","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vetmic.2009.07.011","article-title":"Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1","volume":"140","author":"Zhang","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0969-2126(96)00017-2","article-title":"Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity","volume":"4","author":"Curry","year":"1996","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2020.04.006_b0055","doi-asserted-by":"crossref","unstructured":"OIE. Infection With Foot and Mouth Disease. Terr. Anim. Heal. Code, vol. II, 2018, p. 1\u201324. doi:10.1017\/CBO9781107415324.004.","DOI":"10.1017\/CBO9781107415324.004"},{"key":"10.1016\/j.vaccine.2020.04.006_b0060","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1016\/j.vaccine.2006.10.052","article-title":"Global FMD control-Is it an option?","volume":"25","author":"Kitching","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.006_b0065","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00705-019-04216-x","article-title":"Foot-and-mouth disease vaccines: recent updates and future perspectives","volume":"164","author":"Kamel","year":"2019","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1297-9716-44-116","article-title":"Foot-and-mouth disease: Past, present and future","volume":"44","author":"Jamal","year":"2013","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2020.04.006_b0075","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1128\/JVI.79.12.7698-7706.2005","article-title":"Factors required for the uridylylation of the Foot-and-Mouth Disease Virus 3B1, 3B2, and 3B3 Peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro","volume":"79","author":"Nayak","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0080","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/molecules22122199","article-title":"Conserved binding regions provide the clue for peptide-based vaccine development: a chemical perspective","volume":"22","author":"Curtidor","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2020.04.006_b0085","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis. I. The synthesis of tetrapeptide","volume":"85","author":"Merrifield","year":"1963","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2020.04.006_b0090","unstructured":"Ram\u00edrez GC, Vera V, Villamil LC. Cultivo de c\u00e9lulas animales. 1st ed. Bogot\u00e1 D.C., Colombia: Universidad Nacional de Colombia; 2005."},{"key":"10.1016\/j.vaccine.2020.04.006_b0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0196-9781(03)00135-9","article-title":"Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes","volume":"24","author":"Garc\u00eda","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.vaccine.2020.04.006_b0100","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0264-410X(01)00472-8","article-title":"Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes","volume":"20","author":"Rodr\u00edguez","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.006_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2010.09.017","article-title":"The Mycobacterium tuberculosis membrane protein Rv0180c: Evaluation of peptide sequences implicated in mycobacterial invasion of two human cell lines","volume":"32","author":"C\u00e1ceres","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.vaccine.2020.04.006_b0110","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1582-4934.2008.00174.x","article-title":"Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines","volume":"12","author":"Patarroyo","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.vaccine.2020.04.006_b0115","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/cr100223m","article-title":"Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development","volume":"111","author":"Patarroyo","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.vaccine.2020.04.006_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.2015.1075505","article-title":"Recent advances in the development of a chemically synthesised anti-malarial vaccine","volume":"15","author":"Curtidor","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2020.04.006_b0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0969-2126(00)00014-9","article-title":"The structure and antigenicity of a type-C Foot-and-Mouth-Disease Virus","volume":"2","author":"Lea","year":"1994","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2020.04.006_b0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/362566a0","article-title":"Structure of a major immunogenic site on foot-and-mouth disease virus","volume":"362","author":"Logan","year":"1993","journal-title":"Nat Lett"},{"key":"10.1016\/j.vaccine.2020.04.006_b0135","doi-asserted-by":"crossref","unstructured":"Adams P, Lea S, Newman J, Blakemore W, King A, Stuart D, et al. The structure of foot and mouth Disease virus serotype SAT1 (PDB ID: 2WZR) 2010. doi:10.2210\/pdb2WZR\/pdb.","DOI":"10.2210\/pdb2wzr\/pdb"},{"key":"10.1016\/j.vaccine.2020.04.006_b0140","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1099\/vir.0.80730-0","article-title":"Structure of Foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: Receptor conservation in the face of antigenic variation","volume":"86","author":"Fry","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2014 A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.vaccine.2020.04.006_b0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2052.2001.00761.x","article-title":"Multi-primer target PCR for rapid identification of bovine DRB3 alleles","volume":"32","author":"Ledwidge","year":"2001","journal-title":"Anim Genet"},{"key":"10.1016\/j.vaccine.2020.04.006_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2008.09.013","article-title":"Simple approach to reduce PCR artefact formation leads to reliable genotyping of MHC and other highly polymorphic loci - Implications for evolutionary analysis","volume":"427","author":"Lenz","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2020.04.006_b0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2052.2008.01757.x","article-title":"A rapid and robust sequence-based genotyping method for BoLA-DRB3 alleles in large numbers of heterozygous cattle","volume":"39","author":"Baxter","year":"2008","journal-title":"Anim Genet"},{"key":"10.1016\/j.vaccine.2020.04.006_b0165","doi-asserted-by":"crossref","unstructured":"OIE. Foot and mouth disease. 2009. doi:10.1177\/146642401303400206.","DOI":"10.1177\/146642401303400206"},{"key":"10.1016\/j.vaccine.2020.04.006_b0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13073-018-0594-6","article-title":"Footprints of antigen processing boost MHC class II natural ligand predictions","volume":"10","author":"Barra","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.vaccine.2020.04.006_b0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2020.04.006_b0180","first-page":"14","article-title":"GeneDoc: analysis and visualization of genetic variation","volume":"4","author":"Nicholas","year":"1997","journal-title":"EMBnet News"},{"key":"10.1016\/j.vaccine.2020.04.006_b0185","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00251-006-0127-0","article-title":"Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB lineages","volume":"58","author":"Su\u00e1rez","year":"2006","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2020.04.006_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12863-018-0618-7","article-title":"Genetic diversity of BoLA-DRB3 in South American Zebu cattle populations","volume":"19","author":"Takeshima","year":"2018","journal-title":"BMC Genet"},{"key":"10.1016\/j.vaccine.2020.04.006_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tan.12481","article-title":"Assessment of biodiversity in Chilean cattle using the distribution of major histocompatibility complex class II BoLA-DRB3 allele","volume":"85","author":"Takeshima","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2020.04.006_b0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gene.2013.01.002","article-title":"Characterization of bovine MHC DRB3 diversity in Latin American Creole cattle breeds","volume":"519","author":"Giovambattista","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2020.04.006_b0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vaccine.2009.09.131","article-title":"BoLA-DR peptide binding pockets are fundamental for foot-and-mouth disease virus vaccine design in cattle","volume":"28","author":"Baxter","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.006_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185184","article-title":"Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle","volume":"12","author":"Soria","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.006_b0215","first-page":"12","article-title":"Immune response and partial protection against heterologous foot-and-mouth disease virus Iinduced by dendrimer peptides in cattle","author":"Soria","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2020.04.006_b0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3923\/ijp.2017.122.133","article-title":"In silico design, synthesis and potency of an epitope-based vaccine against foot-and-mouth disease virus","volume":"13","author":"Liu","year":"2017","journal-title":"Int J Pharmacol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.04.006_b0225","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1099\/0022-1317-69-10-2483","article-title":"Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides","volume":"69","author":"Francis","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3844\/ajisp.2013.48.57","article-title":"Immunological response in bovine lymph nodes stimulated with subunits vaccines","volume":"9","author":"Tafur Gomez","year":"2013","journal-title":"Am J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/298030a0","article-title":"Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence","volume":"298","author":"Bittle","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.006_b0240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.3008333","article-title":"Protection of cattle against foot-and-mouth disease by a synthetic peptide","volume":"232","author":"DiMarchi","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.04.006_b0245","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/eji.1830181222","article-title":"Orientation of epitopes influences the immunogenicity of synthetic peptide dimmers","volume":"18","author":"Cox","year":"1988","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.006_b0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0264-410X(89)90007-8","article-title":"Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator","volume":"7","author":"Wiesm\u00fcller","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.006_b0255","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/330168a0","article-title":"Non-responsive to a foot-and-mouth disease virus peptide overcome by addition of foreing helper T-cell determinants","volume":"330","author":"Francis","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.006_b0260","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/jvi.62.4.1469-1473.1988","article-title":"VP1 of serotype C foot-and-mouth disease viruses: long-term long-term conservation of sequences","volume":"62","author":"Piccone","year":"1988","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:42Z","timestamp":1759401762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":52,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304643"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}